Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry

By  

Liver Cancer, Vol. 5, Iss. 1, 2016-0 ,pp. : 37-46

Karger

Access to resources Recommend Favorite

Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma

By Heinzow Hauke Sebastian   Meister Tobias   Nass Dominik   Kööhler Michael   Spieker Tilmann   Wolters Heiner   Domschke Wolfram   Domagk Dirk  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 2, 2011-02 ,pp. : 201-210

Informa Healthcare

Access to resources Recommend Favorite

Combination of Local Transcatheter Arterial Chemoembolization and Systemic Anti-Angiogenic Therapy for Unresectable Hepatocellular Carcinoma

By  

Liver Cancer, Vol. 1, Iss. 3-4, 2012-11 ,pp. : 201-215

Karger

Access to resources Recommend Favorite

Multimodality Treatment with Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma

By  

Digestion, Vol. 85, Iss. 1, 2011-12 ,pp. : 18-26

Karger

Access to resources Recommend Favorite

Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma

By Kinugasa Hideaki  

Journal of Gastroenterology, Vol. 47, Iss. 4, 2012-04 ,pp. : 421-426

Springer Publishing Company

Access to resources Recommend Favorite